Prostate Cancer - Results from #26280

Continence rate and oncological feasibility after total transurethral resection of the prostate as an alternative therapy for the treatment of prostate cancer: A pilot study - Abstract February 13, 2012

Clinical efficacy of TroVax in the treatment of progressive castration-resistant prostate cancer - Abstract February 10, 2012

Low testosterone level predicts prostate cancer in re-biopsy in patients with high grade prostatic intraepithelial neoplasia - Abstract February 10, 2012

Will SBRT replace conventional radiotherapy in patients with low-intermediate risk prostate cancer? A review - Abstract February 10, 2012

Does antibiotherapy prevent unnecessary prostate biopsies in patients with high PSA values? - Abstract February 10, 2012

WCE 2011 - What should we measure? Predicting outcomes with flexible ureteroscopy for large renal stones - Session Highlights February 10, 2012

WCE 2011 - Human versus robot: Who can perform more accurate prostate biopsy? - Session Highlights February 10, 2012

Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and younger - Abstract February 9, 2012

The emerging role of diffusion-weighted MRI in prostate cancer management - Abstract February 9, 2012

Impact of distance to a urologist on early diagnosis of prostate cancer among black and white patients - Abstract February 9, 2012

Androgen deprivation therapy in prostate cancer: Focusing on sexual side effects - Abstract February 9, 2012

Seven years of experience with high-intensity focused ultrasound for prostate cancer: Advantages and limitations - Abstract February 9, 2012

Distinct redox profiles of selected human prostate carcinoma cell lines: Implications for rational design of redox therapy - Abstract February 8, 2012

Unilateral exophthalmos revealing metastatic prostate cancer - Abstract February 8, 2012

Long-term outcomes of open radical retropubic prostatectomy for clinically localized prostate cancer in the prostate-specific antigen era - Abstract February 8, 2012

Understanding variation in primary prostate cancer treatment within the Veterans Health Administration - Abstract February 8, 2012

Racial differences in bone mineral density and fractures in men receiving androgen deprivation therapy for prostate cancer - Abstract February 8, 2012

Acceptability and preliminary feasibility of an Internet/CD-ROM-based education and decision program for early-stage prostate cancer patients: Randomized pilot study - Abstract February 8, 2012

Explaining racial differences in prostate cancer mortality - Abstract February 8, 2012

Detection and localization of prostate cancer with the targeted biopsy strategy based on ADC Map: A prospective large-scale cohort study - Abstract February 8, 2012

Page 1315 of 1436